A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
Clinical trial NCT04349072 · COMPLETED
Trial details
- NCT number
- NCT04349072
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2022-02-07
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.